uploads/2018/03/doctors-office-checkup-medical-2610509.jpg

Analysts’ Ratings for AmerisourceBergen in March 2018

By

Updated

AmerisourceBergen

AmerisourceBergen (ABC) is one of the largest global pharmaceutical sourcing and distribution services companies. The company caters to healthcare providers as well as pharmaceutical and biotech manufacturers. AmerisourceBergen delivers innovative programs and services designed to increase the effectiveness of the pharmaceutical supply chain in human and animal health. The company operates through two business segments—pharmaceutical distribution services and the other segment.

Article continues below advertisement

Analysts’ recommendations

Of the 18 analysts covering AmerisourceBergen in March 2018, four analysts gave the stock a “strong buy” rating, seven analysts gave it a “buy” rating, and seven analysts gave it a “hold” rating. The stock’s mean rating is 2.17 with a target price of $106.13.

Peers’ ratings

Of the 19 analysts covering Cardinal Health (CAH) in March 2018, one analyst gave the stock a “buy” rating, 16 analysts gave it a “hold” rating, and two analysts gave it a “sell” rating. The stock’s mean rating is 3.05 with a target price of $73.93.

Of the 25 analysts covering CVS Health (CVS) in March 2018, eight analysts gave the stock a “strong buy” rating, ten analysts gave it a “buy” rating, and seven analysts gave it a “hold” rating. The stock’s mean rating is 1.96 with a target price of $88.55.

Of the 24 analysts covering Express Scripts Holding (ESRX) in March 2018, three analysts gave the stock a “strong buy” rating, seven analysts gave it a “buy” rating, nine analysts gave it a “hold” rating, and five analysts gave it a “sell” or a lower rating. The stock’s mean rating is 2.75 with a target price of $84.39.

Next, we’ll discuss AmerisourceBergen’s business segments.

Advertisement

More From Market Realist